NCT00486473View on ClinicalTrials.gov

Multihance Versus Magnevist in Breast MRI

PHASE3CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Breast Cancer
Interventions
DRUG

Multihance

0.5 Molar at a single dose injection

DRUG

Magnevist

0.5M at a single dose injection

Trial Locations (1)

Unknown

Rome

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY